Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Technical eligibility for treatment of magnetic resonance-guided focused ultrasound surgery.

Fröling V, Kröncke TJ, Schreiter NF, Scheurig-Muenkler C, Collettini F, Hamm B, Beck A.

Cardiovasc Intervent Radiol. 2014 Apr;37(2):445-50. doi: 10.1007/s00270-013-0678-z.

PMID:
23839005
2.

[Clinical outcome of magnetic-resonance-guided focused ultrasound surgery (MRgFUS) in the treatment of symptomatic uterine fibroids].

Kamp JE, David M, Scheurig-Muenkler C, Hengst S, Beck A.

Rofo. 2013 Feb;185(2):136-43. doi: 10.1055/s-0032-1325512. German.

PMID:
23196835
3.

[Principles and technique of magnetic resonance guided focused ultrasound surgery (MRgFUS) in the treatment of uterine fibroids].

Vázquez-Lamadrid J, Fernández-de Lara Y, Carrasco-Choque A, Romero-Trejo C, Cosme-Labarthe J, Roldan-Valadez E.

Gac Med Mex. 2011 Jul-Aug;147(4):333-41. Review. Spanish.

PMID:
21894231
4.

Patient suitability for magnetic resonance guided focused ultrasound surgery of uterine fibroids.

Zaher S, Gedroyc WM, Regan L.

Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):98-102. doi: 10.1016/j.ejogrb.2008.12.011.

PMID:
19185968
5.

MR-guided focus ultrasound (MRgFUS) for symptomatic uterine fibroids: predictors of treatment success.

Machtinger R, Inbar Y, Cohen-Eylon S, Admon D, Alagem-Mizrachi A, Rabinovici J.

Hum Reprod. 2012 Dec;27(12):3425-31. doi: 10.1093/humrep/des333.

6.

PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids.

Jacoby VL, Kohi MP, Poder L, Jacoby A, Lager J, Schembri M, Rieke V, Grady D, Vittinghoff E, Coakley FV.

Fertil Steril. 2016 Mar;105(3):773-80. doi: 10.1016/j.fertnstert.2015.11.014.

PMID:
26658133
7.

Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids.

Quinn SD, Vedelago J, Gedroyc W, Regan L.

Eur J Obstet Gynecol Reprod Biol. 2014 Nov;182:247-51. doi: 10.1016/j.ejogrb.2014.09.039.

PMID:
25445107
8.

Patient selection guidelines in MR-guided focused ultrasound surgery of uterine fibroids: a pictorial guide to relevant findings in screening pelvic MRI.

Yoon SW, Lee C, Cha SH, Yu JS, Na YJ, Kim KA, Jung SG, Kim SJ.

Eur Radiol. 2008 Dec;18(12):2997-3006. doi: 10.1007/s00330-008-1086-7.

PMID:
18618119
9.
10.

Midterm results after uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for symptomatic uterine fibroids.

Froeling V, Meckelburg K, Scheurig-Muenkler C, Schreiter NF, Kamp J, Maurer MH, Beck A, Hamm B, Kroencke TJ.

Cardiovasc Intervent Radiol. 2013 Dec;36(6):1508-13. doi: 10.1007/s00270-013-0582-6.

PMID:
23456309
11.

Clinical predictors of successful magnetic resonance-guided focused ultrasound (MRgFUS) for uterine leiomyoma.

Gorny KR, Borah BJ, Weaver AL, Brown D, Woodrum DA, Stewart EA, Hesley GK.

J Ther Ultrasound. 2013 Sep 2;1:15. doi: 10.1186/2050-5736-1-15.

12.

Mid-term clinical efficacy of a volumetric magnetic resonance-guided high-intensity focused ultrasound technique for treatment of symptomatic uterine fibroids.

Ikink ME, Voogt MJ, Verkooijen HM, Lohle PN, Schweitzer KJ, Franx A, Mali WP, Bartels LW, van den Bosch MA.

Eur Radiol. 2013 Nov;23(11):3054-61. doi: 10.1007/s00330-013-2915-x.

PMID:
23793518
14.

Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids.

Funaki K, Sawada K, Maeda F, Nagai S.

J Obstet Gynaecol Res. 2007 Dec;33(6):834-9.

PMID:
18001451
15.

MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre.

Mindjuk I, Trumm CG, Herzog P, Stahl R, Matzko M.

Eur Radiol. 2015 May;25(5):1317-28. doi: 10.1007/s00330-014-3538-6.

PMID:
25510445
16.

Features influencing patient selection for fibroid treatment with magnetic resonance-guided focused ultrasound.

Arleo EK, Khilnani NM, Ng A, Min RJ.

J Vasc Interv Radiol. 2007 May;18(5):681-5.

PMID:
17494853
17.

Uterine artery embolization for severe symptomatic fibroids: effects on fertility and symptoms.

Torre A, Paillusson B, Fain V, Labauge P, Pelage JP, Fauconnier A.

Hum Reprod. 2014 Mar;29(3):490-501. doi: 10.1093/humrep/det459.

18.

Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.

Babashov V, Palimaka S, Blackhouse G, O'Reilly D.

Ont Health Technol Assess Ser. 2015 Mar 1;15(5):1-61.

19.

Eligibility and accessibility of magnetic resonance-guided focused ultrasound (MRgFUS) for the treatment of uterine leiomyomas.

Behera MA, Leong M, Johnson L, Brown H.

Fertil Steril. 2010 Oct;94(5):1864-8. doi: 10.1016/j.fertnstert.2009.09.063.

PMID:
19931074
20.

Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids.

O'Sullivan AK, Thompson D, Chu P, Lee DW, Stewart EA, Weinstein MC.

Int J Technol Assess Health Care. 2009 Jan;25(1):14-25. doi: 10.1017/S0266462309090035.

Items per page

Supplemental Content

Support Center